Clin2
NCT07649408Possibly a fitRecruiting

How New Crohn's Treatments Affect Sleep Quality

Crohn Disease (CD)

Part of Digestive system clinical trials.

This study looks at whether new biologic or targeted medications for Crohn's disease improve sleep quality. You would wear a watch while sleeping and answer questions about your sleep to help researchers understand if these advanced treatments help you sleep better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have a confirmed diagnosis of Crohn's disease (not ulcerative colitis or indeterminate IBD)
  • Your Crohn's disease is currently active with measurable inflammation (high HBI score and elevated blood/stool markers)
  • You are starting one of these advanced treatments: anti-TNF, vedolizumab, ustekinumab, IL-23 inhibitor, JAK inhibitor, or S1P inhibitor
  • You are able and willing to wear a watch while sleeping and complete questionnaires throughout the study
  • You do not have other diagnosed sleep disorders and are not taking sleep medications like benzodiazepines or cannabis
  • You have not had abdominal surgery in the past 4 weeks and do not have an ileostomy or short bowel syndrome

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06976853Recruiting· Phase 2
Testing a new drug for Crohn’s disease beyond inflammation

This study tests a medicine called tirzepatide to see if it can help people with active Crohn’s disease who have not responded to multiple prior treatments. It focuses on how the drug might work beyond just reducing inflammation.

Beverly Hills, California
NCT07159776Not yet recruiting
Digital tools to improve care for IBD patients

This study uses a smartphone app and activity tracker to monitor how people with Crohn's disease, ulcerative colitis, or unspecified IBD feel day to day. It may help doctors better understand and manage your condition through digital health data.

Bonheiden
NCT06494826Recruiting
Study of gut bacteria and proteins in new Crohn's disease patients

This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.

Afula
NCT05835973Recruiting
Study of sleep changes in people with inflammatory bowel disease

This study looks at how sleep patterns change in adults with inflammatory bowel disease (IBD) who are currently in remission. It may help researchers understand sleep issues in IBD and identify ways to improve care during symptom-free periods.

Clermont-Ferrand
NCT06359808Recruiting
Sleep Problems in Ulcerative Colitis Patients

This study looks at sleep problems in people with ulcerative colitis (a type of inflammatory bowel disease). It aims to understand how sleep affects your condition and may help find better ways to manage both.

Xi'an, Shaanxi
NCT07737665Recruiting· Phase 4
Melatonin for better sleep in IBD patients in remission

This study tests whether melatonin (a natural sleep hormone) can improve sleep quality in people with inflammatory bowel disease (IBD) whose disease is quiet (in remission). If you have IBD and trouble sleeping, you may be able to join.

Bangkok Noi, Bangkok

Hear when a new Crohn Disease (CD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.